3Kollef MH, Sherman G, Ward S, et al. Inadequate antimicrobial treatment of infections :a risk factor for hospital mortality among critically ill patients. Chest 11999,115:462-474. 被引量：1
4Ben-David D, Rubinstein E. Appropriate use of antibiotics for respiratory infections:review of recent statements and position papers. Curr Opin Infect Dis ,2002,15 : 151-156. 被引量：1
5Colodner R, Rock W, Chazan B, et al. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis,2004,23 : 163-167. 被引量：1
6Paramythiotou E, Lucet JC, Timsit JF, et al. Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units : role of antibiotics with antipseudomonal activity. Clin Infect Dis ,2004,38 :670-677. 被引量：1
7Munday C J, Whitehead GM, Todd N J, et al. Predominance and genetic diversity of community-and hospital-acquired CTX-M extended-spectrum beta-lactamases in York, UK. J Antimicrob Chemother,2004,54:628-633. 被引量：1
8Woodford N, Ward ME, Kaufmarm ME, et al, Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob C hemother, 2004,54 : 735 -743. 被引量：1
9Valverde A, Coque TM, Sánchez-Moreno MP, et al. Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol,2004,42 :4769-4775. 被引量：1
10Livermore DM. The need for new antibiotics. Clin Microbiol Infect,2004,10 ( Suppl 4 ) : 1-9. 被引量：1
